10 Best Specialty Drug Prior Authorization Software

Quick answer: The best specialty drug prior authorization software in 2026 has to span a split that defines the category — the medical benefit (buy-and-bill, J-code infusions a practice buys and bills) versus the pharmacy benefit (biologics dispensed through a specialty pharmacy). Honey Health leads for practices that want specialty-drug PAs submitted and chased across both benefits and every payer inside their existing EHR. SamaCare and Mandolin own buy-and-bill and infusion; CoverMyMeds, Tandem, and Develop Health handle pharmacy-benefit biologics; AssistRx and CareMetx run specialty therapy initiation and hub services; Myndshft determines requirements; and Humata automates touchless. The right pick depends on whether your specialty drugs run through the medical or pharmacy benefit.

Specialty drugs — biologics, infusions, and the high-cost therapies behind conditions like rheumatoid arthritis, Crohn's, cancer, and multiple sclerosis — are where prior authorization gets most complicated and most expensive. A single therapy can require benefit investigation, prior authorization, patient assistance enrollment, and ongoing reauthorization, with thousands of dollars and a patient's treatment hanging on each step. The software market built to handle this is fragmented because the workflow itself is fragmented, splitting along a line most other PA categories never have to think about.

That line is the benefit. Some specialty drugs run through the pharmacy benefit and a specialty pharmacy; others — the J-code injectables and infusions a practice buys, administers, and bills directly — run through the medical benefit. The documentation, the portals, and the vendors differ on each side, which is why a tool that's excellent at buy-and-bill infusion PA may be silent on pharmacy-benefit biologics, and vice versa. Choosing well starts with knowing which side your drugs live on.

This guide ranks the software that handles specialty drug PA in 2026 across both sides of that split, with a clear best-fit and an honest read on where each one stops. It's a spoke of our prior authorization software hub and a close cousin of our medication PA software guide; for the AI-native shortlist, see the AI specialty drug PA tools companion.

Last updated: June 2026.

The buy-and-bill versus pharmacy-benefit split

Understanding specialty drug PA means understanding the two paths a specialty therapy can take. On the pharmacy-benefit side, the drug is prescribed and dispensed through a specialty pharmacy, the PA runs through the pharmacy benefit manager, and tools like CoverMyMeds, Tandem, and Develop Health handle the electronic prior authorization at or near the point of prescription. On the medical-benefit side — buy-and-bill — the practice purchases the drug, administers it in-office or at an infusion center, and bills it under a J-code, with the PA running through the medical benefit; SamaCare and Mandolin are built for exactly this.

The split matters because it changes everything downstream: the forms, the payer portals, the reimbursement risk, and even the financial exposure, since a buy-and-bill practice has often already purchased a costly drug before the claim is paid. Many specialty practices live on both sides at once — a rheumatology or GI group may have biologics on the pharmacy benefit and infusions on the medical benefit — which is why a tool that works across both, or a broad agent that handles whichever path a given drug takes, removes the most friction. Hub-services platforms like AssistRx and CareMetx wrap around this complexity with benefit investigation, enrollment, and patient assistance layered on top of the PA itself.

How we evaluated specialty drug PA software

We focused on software that does real specialty-drug PA work — biologics, infusions, and buy-and-bill therapies — across the full field of pharmacy-benefit tools, medical-benefit platforms, and hub-services vendors. The dimensions that separated the field:

• Which benefit it serves — pharmacy benefit, medical benefit (buy-and-bill), or both?
• Workflow scope — PA only, or benefit investigation, enrollment, and reauthorization too?
• Autonomy — does it route the request, or submit and chase it to a decision?
• EHR and portal fit — does it operate across the payers and portals you use?
• Reauthorization handling — does it manage the recurring renewals specialty drugs require?

There's no single right answer here. An infusion center buried in J-code authorizations and a dermatology practice prescribing pharmacy-benefit biologics need different tools, so each entry carries a clear best-fit. The financial stakes are unusually high — specialty drugs are among the most expensive line items in healthcare — which is why getting the authorization right the first time matters more here than almost anywhere else.

Specialty drug PA software at a glance

The 10 best specialty drug PA software platforms in 2026

1. Honey Health — best for end-to-end specialty PA across both benefits

Honey Health handles specialty drug PA without caring which side of the benefit split a given therapy falls on. Its AI agent identifies the PA requirement in the EMR, assembles the clinical justification — diagnosis, prior therapies, lab values — logs into the right payer portal whether the drug runs through the medical or pharmacy benefit, submits, monitors status, and writes the decision back to the chart. Because it works through agentic browser automation rather than a built integration, it operates the payer portals and the 20+ EHRs your staff already use, which matters in specialty care where a practice often straddles both benefits at once.

For a specialty practice, the value is in not having to stitch together a buy-and-bill tool and a pharmacy-benefit tool: one agent works a J-code infusion authorization and a pharmacy-benefit biologic with the same approach, and chases each to a decision. Pricing runs per completed PA — about $1.50 to $2 including follow-up — and Honey reports practices offsetting roughly one full-time coordinator per 25 new PAs a day, 80 to 95 percent less manual effort, and 99.8 to 99.9 percent task accuracy, with complex cases routed to a person.

Honey works the provider's side and doesn't replace the deep hub-services and patient-assistance layers that some specialty therapies require, and it's a newer name than the established specialty vendors here, so buyers should confirm coverage for their drug and payer mix. For specialty practices that want one agent working both medical and pharmacy-benefit drug PAs end to end inside their existing EHR, it's the most unified option on this list.

2. SamaCare — best for buy-and-bill (J-code) drug PA

SamaCare is purpose-built for the medical-benefit side: the J-code injectables and infusions a practice buys, administers, and bills. Its end-to-end platform, built on AI trained on more than two million prior authorizations, handles the buy-and-bill PA workflow that specialty practices struggle with most, and it reports processing billions of dollars in drug authorizations. A $17 million Series B in 2024 supported its growth across rheumatology, oncology, ophthalmology, and dermatology.

The platform's depth on buy-and-bill is exactly what makes it specific — it's sharp on medical-benefit drugs and doesn't aim at pharmacy-benefit ePA, and it reads more as an AI-accelerated workflow than a fully autonomous agent. For specialty practices whose biggest PA pain is buy-and-bill infusions and injectables, that focus is the point rather than a drawback. Best for specialty practices drowning in J-code, medical-benefit drug authorizations.

3. Mandolin — best for infusion and specialty-pharmacy access

Mandolin is an agentic platform for specialty-drug administration at infusion centers and specialty pharmacies, where prior authorization is one piece of a wider flow that also handles benefits investigation, patient cost, co-pay assistance, and 340B pricing. It raised a combined $40 million in 2025 and reports deployment across more than 700 clinic locations, positioning it as a full operating system for specialty-drug access rather than a PA point tool.

That breadth is its signature and its boundary: Mandolin goes deep on specialty drugs and infusion workflows and isn't built for general retail-pharmacy PA, so its fit is specific to organizations whose business is specialty administration. For an infusion center that wants PA embedded in the full access workflow — benefits, assistance, 340B, and all — it's hard to match. Best for infusion centers and specialty pharmacies that want PA inside a complete specialty-drug access platform.

4. CoverMyMeds — best for pharmacy-benefit specialty enrollment and ePA

CoverMyMeds (McKesson) is the de facto standard for electronic prior authorization on the pharmacy benefit, free to providers and pharmacies through its sponsor-funded model, and its 2025 acquisition of RxLightning extended it deep into specialty medication enrollment, digitizing intake for more than 1,600 specialty drugs. For pharmacy-benefit specialty therapies, it's the ubiquitous rail most EHRs and specialty pharmacies already touch.

CoverMyMeds submits and routes the ePA and now handles much of the specialty enrollment paperwork, but the back-and-forth and status-chasing on harder authorizations still fall to staff, and its center of gravity is the pharmacy benefit rather than buy-and-bill medical drugs. For practices and specialty pharmacies whose specialty volume runs through the pharmacy benefit, it's the standard starting point. Best for pharmacy-benefit specialty enrollment and ePA at no software cost.

5. Tandem (Forus) — best for free biologic PA at prescription

Tandem, through Forus, automates medication and biologic prior authorization from the prescription written in the EHR — generating the form, submitting, following up, and handling appeals, plus pharma patient-assistance enrollment — and it's free to providers and patients, funded through pharma partnerships. It reached a reported $137 million in funding and a $1 billion valuation in early 2026, with strong adoption in GI, dermatology, and rheumatology, exactly the specialties where biologics dominate.

Forus concentrates on medication and biologic PA and nothing else, and its pharma-funded model ties its economics to drug access, which buyers should weigh against a neutral, practice-paid tool. For a specialty group with heavy pharmacy-benefit biologic volume that wants those authorizations handled at no software cost, the trade is often worth it. Best for specialty practices wanting free, point-of-prescription biologic PA.

6. AssistRx — best for specialty therapy initiation

AssistRx centers on getting a specialty therapy started, and its iAssist platform provides automated, pre-populated prior authorization forms that guide a user through submission as part of a broader therapy-initiation and patient-access workflow. It sits in the hub-services tradition, wrapping enrollment, benefit verification, and PA around the launch of a specialty drug.

As a hub-services platform, AssistRx is oriented toward the initiation and access journey rather than functioning as an autonomous PA agent that chases every request to a decision, so it fits organizations that want a guided, structured specialty-onboarding flow. For specialty practices and programs focused on smooth therapy starts with PA built into the process, it's a strong option. Best for specialty therapy initiation with prior authorization built into onboarding.

7. CareMetx — best for specialty hub and patient access

CareMetx runs a specialty patient-access and hub-services platform that unifies benefit verification, prior authorization, and the broader hub workflow specialty drugs require, and in March 2026 it launched a next-generation CRM to tie patient access, real-time insight, and care coordination together. It's built for the full specialty-access lifecycle rather than the PA step in isolation.

CareMetx's hub-services orientation means it's deepest where a specialty program needs end-to-end access coordination, and lighter as a standalone, self-serve PA tool for a practice that just wants authorizations submitted and chased. For manufacturers, hubs, and specialty programs that want patient access and PA managed as one coordinated workflow, it's purpose-built. Best for specialty hub services and patient access with PA integrated.

8. Myndshft (DrFirst) — best for determining specialty PA requirements

Myndshft, now part of DrFirst, answers the upfront question for specialty drugs: does this therapy require prior authorization for this patient's plan, on which benefit, and what does the payer want to see? It provides real-time determination plus benefit and eligibility data across both medical and pharmacy benefits, which is especially useful in specialty care where a drug's benefit path isn't always obvious.

Its strength is that determination-and-eligibility step rather than carrying a specialty request through documentation, submission, and reauthorization, so it tends to pair with a submission tool rather than replace one. For specialty teams, that early clarity prevents both unnecessary requests and the costly surprise of a missed authorization on an expensive drug. Best for determining whether a specialty drug needs a PA and on which benefit.

9. Develop Health — best for AI pharmacy-benefit PA at prescribing

Develop Health is a GenAI platform that predicts a medication's coverage, cost, and requirements at the moment of prescription, then automates benefit verification, the PA, and payer follow-up, auto-filling forms from EHR data. It raised $14.3 million in 2025 and continues expanding its EHR and PBM integrations, with strength on the pharmacy-benefit side where specialty biologics are prescribed.

Develop Health concentrates on the pharmacy benefit, so a practice with significant buy-and-bill volume will cover the medical side elsewhere, and its value peaks where prescribers act on real-time coverage signals at the visit. For specialty groups whose biologic volume runs through the pharmacy benefit and who want coverage answered at the point of prescription, it's a strong AI option. Best for AI-driven pharmacy-benefit specialty PA at prescribing.

10. Humata Health — best for touchless PA across drugs and procedures

Humata Health automates prior authorization across specialty drugs and medical procedures for both providers and payers, with AI policy matching, automated statusing, and gold-carding aimed at roughly 90 percent touchless authorizations. Its roots are in Olive AI's prior-authorization business, and it raised about $25 million in 2024, with specialty drugs and procedures both in scope.

Spanning drugs and procedures across both sides of the transaction gives Humata reach, and it lands most naturally with enterprise revenue-cycle teams and health systems that can deploy it broadly rather than a single specialty clinic. A smaller specialty practice may find it heavier than a focused tool, and its touchless rate depends on the payer and drug mix. Best for health systems and large groups wanting touchless PA spanning specialty drugs and procedures.

How to choose specialty drug PA software

Start by mapping your drugs to the benefit split, because it organizes the entire decision. If your specialty volume is buy-and-bill — J-code infusions and injectables you purchase and administer — your shortlist centers on SamaCare and Mandolin. If it runs through the pharmacy benefit — biologics dispensed by a specialty pharmacy — it centers on CoverMyMeds, Tandem, and Develop Health. If you straddle both, as many rheumatology, GI, oncology, and dermatology groups do, a tool that works across both benefits or a broad agent that handles whichever path a drug takes saves you from running two systems.

Then decide how much of the surrounding workflow you need. Specialty drugs come with benefit investigation, patient assistance, and recurring reauthorization, not just the initial PA. Hub-services platforms (AssistRx, CareMetx) wrap that whole journey together and suit programs and manufacturers; a focused PA agent suits a practice that mainly needs authorizations submitted and chased; and a determination tool (Myndshft) answers the upfront question before either.

Weigh the financial exposure honestly, because it's higher here than in any other PA category. A buy-and-bill practice may have spent thousands on a drug before the claim clears, so a tool that gets the authorization right the first time and chases it to a confirmed decision protects real money, not just staff time. Favor tools that don't just submit but confirm, and that manage the reauthorizations that keep a patient on therapy.

Finally, account for breadth versus depth. The specialty specialists go deep on their slice; a broad agent like Honey Health's trades some of that depth for working every drug and benefit in one place inside your EHR. Match that choice to whether your pain is concentrated in one workflow or spread across many. For the AI-native shortlist, see our AI specialty drug PA tools guide; for retail medication PA, see the medication PA software companion.

Frequently asked questions

What is specialty drug prior authorization software?

Specialty drug prior authorization software helps a practice or pharmacy get payer approval for high-cost biologics and infusions before they're dispensed or administered. The strongest tools determine whether a drug needs a PA and on which benefit, assemble the clinical justification, submit across payer portals, and manage the recurring reauthorizations specialty therapies require.

What's the difference between buy-and-bill and pharmacy-benefit specialty drugs?

Buy-and-bill (medical-benefit) drugs are J-code injectables and infusions a practice purchases, administers in-office or at an infusion center, and bills under the medical benefit — SamaCare and Mandolin specialize here. Pharmacy-benefit specialty drugs are biologics prescribed and dispensed through a specialty pharmacy under the pharmacy benefit — CoverMyMeds, Tandem, and Develop Health handle these. The PA path, portals, and vendors differ on each side.

Do specialty drugs need reauthorization?

Yes — most specialty therapies require periodic reauthorization to keep a patient on treatment, often tied to clinical response or a fixed interval. A lapse can interrupt therapy and create a reimbursement gap, so software that tracks expirations and manages renewals — rather than handling only the initial PA — is especially valuable for specialty drugs.

Can one tool handle both medical and pharmacy benefit specialty PAs?

Some can. Determination tools like Myndshft cover both benefits, and a broad agent like Honey Health works a request regardless of which benefit a drug runs through, since it operates the relevant payer portal directly. Many specialty specialists, by contrast, focus on one side — which is why practices straddling both often favor a tool that spans them or pair a buy-and-bill tool with a pharmacy-benefit one.

What are specialty hub services?

Hub services are programs — often manufacturer-sponsored — that coordinate a patient's access to a specialty therapy, bundling benefit investigation, prior authorization, patient assistance and co-pay support, and enrollment. Platforms like AssistRx and CareMetx provide the technology behind these hubs, wrapping the PA step inside the broader access and onboarding journey.

How much does specialty drug PA software cost?

Pricing varies by model. Honey Health charges per completed authorization (about $1.50 to $2); CoverMyMeds and Tandem's Forus are free and sponsor- or pharma-funded; hub-services and workflow platforms price by contract or program; and several vendors don't publish rates. Given the high cost of specialty drugs, weigh any price against the reimbursement risk and staff time a single mishandled authorization represents.

Specialty drug prior authorization is defined by the benefit split, so the first move is always to map your drugs to the medical or pharmacy side, then choose the tool — or the broad agent — that fits. Favor software that confirms authorizations rather than just submitting them and manages the reauthorizations specialty therapies demand, and for a specialty practice that wants both benefit paths worked end to end inside its existing EHR, Honey Health is a strong starting point.